Pulmonary Venoocclusive Disease (PVOD)

Pulmonary Venoocclusive Disease, also known as pulmonary veno-occlusive disease, is related to pulmonary venoocclusive disease 1, autosomal dominant and telangiectasis, and has symptoms including hemoptysis An important gene associated with Pulmonary Venoocclusive Disease is EIF2AK4 (Eukaryotic Translation Initiation Factor 2 Alpha Kinase 4), and among its related pathways/superpathways are Signal Transduction and Human Embryonic Stem Cell Pluripotency. The drugs Bevacizumab and Orange have been mentioned in the context of this disorder. Affiliated tissues include lung and heart, and related phenotypes are Decreased substrate adherent cell growth and Increased human cytomegalovirus (HCMV) strain AD169 replication